These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6267922)

  • 21. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effects at rest and during exercise in long-term treatment with prazosin in chronic congestive heart failure.
    Westheim A; Koss A; Sivertssen E
    Acta Med Scand; 1986; 219(5):449-53. PubMed ID: 3526819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D
    Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic effects of prazosin in CHF.
    Reuben SR; Kuan P; Gale EV; Wilde PM
    Acta Med Scand Suppl; 1981; 652():145-8. PubMed ID: 6949460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of refractory CHF with prazosin: importance of tolerance and tachyphylaxis.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1981; 652():115-24. PubMed ID: 6949458
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prazosin in the treatment of severe chronic congestive cardiac failure.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
    Stein L; Henry DP; Weinberger MH
    Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA; Chatterjee K; Gelberg HJ; Ports TA; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure.
    Colucci WS; Holman BL; Wynne J; Carabello B; Malacoff R; Grossman W; Braunwald E
    Am J Med; 1981 Jul; 71(1):75-80. PubMed ID: 6113759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
    Yui Y; Sakurai T; Nakajima H; Kawai C
    Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.
    Silke B; Hendry WG; Taylor SH
    Br Heart J; 1981 Dec; 46(6):663-70. PubMed ID: 7317235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of prazosin in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Comşulea L; Streian C
    Med Interne; 1984; 22(1):29-33. PubMed ID: 6710045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Win A; Mason DT
    Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of prazosin in severe cardiac insufficiency].
    Timio M; Gentili S; Schiaroli M; Ronconi M
    G Ital Cardiol; 1979; 9(12):1371-7. PubMed ID: 549785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.